review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1161/CIRCRESAHA.107.158410 |
P698 | PubMed publication ID | 17901370 |
P50 | author | Eugenia Gkaliagkousi | Q92512870 |
Albert Ferro | Q37843366 | ||
P2093 | author name string | James Ritter | |
P2860 | cites work | Regulation of endothelium-derived nitric oxide production by the protein kinase Akt | Q22010149 |
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation | Q22010150 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 654-662 | |
P577 | publication date | 2007-09-01 | |
P1433 | published in | Circulation Research | Q2599020 |
P1476 | title | Platelet-derived nitric oxide signaling and regulation | |
P478 | volume | 101 |
Q38563297 | A 'green' diet-based approach to cardiovascular health? Is inorganic nitrate the answer? |
Q54569298 | A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP. |
Q38451947 | A review and discussion of platelet nitric oxide and nitric oxide synthase: do blood platelets produce nitric oxide from L-arginine or nitrite? |
Q91594139 | Acetylcholine Inhibits Platelet Activation |
Q40453632 | Adenylic dinucleotides produced by CD38 are negative endogenous modulators of platelet aggregation. |
Q53641941 | Anti-platelet activity of water dispersible curcuminoids in rat platelets. |
Q42438253 | Aspirin and clopidogrel treatment impair nitric oxide biosynthesis by platelets |
Q92355916 | Attenuation of Thrombin-Mediated Fibrin Formation via Changes in Fibrinogen Conformation Induced by Reaction with S-nitroso-N-acetylpenicillamine, but not S-nitrosoglutathione |
Q49953603 | Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis. |
Q38586940 | Clinical Significance of Endothelial Dysfunction in Essential Hypertension. |
Q36020320 | Clopidogrel treatment may associate with worsening of endothelial function and development of new digital ulcers in patients with systemic sclerosis: results from an open label, proof of concept study |
Q33951689 | Cyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation |
Q42458586 | Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension |
Q45364372 | Dermal application of nitric oxide in vivo: kinetics, biological responses, and therapeutic potential in humans |
Q45857255 | Encapsulated platelets modulate kupffer cell activation and reduce oxidative stress in a model of acute liver failure |
Q98774303 | Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses |
Q51600619 | Endothelin-1 Gene Polymorphism and Its Level Predict the Risk of Venous Thromboembolism in Male Indian Population. |
Q64230266 | Expression and Activity of Platelet Endothelial Nitric Oxide Synthase Are Decreased in Patients with Coronary Thrombosis and Stenosis |
Q51061441 | Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation. |
Q55541493 | Glycerol fructose combined with vitamin B6 is beneficial to postoperative recovery of patients with cerebral aneurysm. |
Q36339645 | High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets |
Q46958961 | In vitro effects of nitric oxide donors on apoptosis and oxidative/nitrative protein modifications in ADP-activated platelets |
Q39128520 | Inhibitory effect of carbazolequinone derivatives on lipopolysaccharide and interferon-γ-induced nitric oxide production in mouse macrophage RAW264.7 cells |
Q90671729 | Intraplatelet L-Arginine-Nitric Oxide Metabolic Pathway: From Discovery to Clinical Implications in Prevention and Treatment of Cardiovascular Disorders |
Q42442493 | Lactate is a possible mediator of the glucose effect on platelet inhibition. |
Q49568718 | Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease. |
Q53286212 | Modulation of NO bioavailability by temporal variation of the cell-free layer width in small arterioles. |
Q37694936 | NO-Synthase Activity in Patients with Coronary Heart Disease Associated with Hypertension of Different Age Groups |
Q42592882 | New mechanisms of antiplatelet activity of nifedipine, an L-type calcium channel blocker |
Q37384860 | Nitric oxide mechanism of protection in ischemia and reperfusion injury |
Q37887771 | Nitric oxide: a guardian for vascular grafts? |
Q28551434 | Piperlongumine Blocks JAK2-STAT3 to Inhibit Collagen-Induced Platelet Reactivity Independent of Reactive Oxygen Species |
Q43186392 | Platelet activation in essential hypertension: implications for antiplatelet treatment |
Q51771267 | Platelet activation in hypertension associated with hypercholesterolemia: effects of irbesartan. |
Q33569525 | Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase |
Q34816571 | Platelet hemostasis in patients with metabolic syndrome and type 2 diabetes mellitus: cGMP- and NO-dependent mechanisms in the insulin-mediated platelet aggregation |
Q36679363 | Platelet nitric oxide signaling system in patients with coronary artery disease |
Q44848891 | Role of inorganic nitrate and nitrite in driving nitric oxide-cGMP-mediated inhibition of platelet aggregation in vitro and in vivo |
Q35948515 | Role of reactive oxygen and nitrogen species in the vascular responses to inflammation |
Q34391779 | S-nitrosoglutathione acts as a small molecule modulator of human fibrin clot architecture |
Q37250033 | Serotonin uptake rates in platelets from angiotensin II-induced hypertensive mice |
Q27022328 | Serotonin: a different player in hypertension-associated thrombosis |
Q90320770 | Short-Term E-Cigarette Exposure Increases the Risk of Thrombogenesis and Enhances Platelet Function in Mice |
Q35235141 | The effects of antidepressants "fluoxetine and imipramine" on vascular abnormalities and Toll like receptor-4 expression in diabetic and non-diabetic rats exposed to chronic stress |
Q53213775 | Transgenic mice overexpressing arginase 1 in monocytic cell lineage are affected by lympho-myeloproliferative disorders and disseminated intravascular coagulation. |
Q34276215 | Xanthohumol, a Prenylated Flavonoid from Hops (Humulus lupulus), Prevents Platelet Activation in Human Platelets |
Search more.